Evidence map›Paper›PMID 33315883›Full record

ArticlePloS one2020

Missing value imputation in proximity extension assay-based targeted proteomics data.

Michael Lenz, Andreas Schulz, Thomas Koeck, Steffen Rapp, Markus Nagler, Madeleine Sauer, Lisa Eggebrecht, Vincent Ten Cate, Marina Panova-Noeva, Jürgen H Prochaska and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Michael LenzInstitute of Organismic and Molecular Evolution, Johannes Gutenberg University Mainz, Mainz, Germany.ORCID 0000-0002-6319-6480
Andreas SchulzPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Thomas KoeckPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Steffen RappPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Markus NaglerPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Madeleine SauerDisease Genomics, Bayer AG, Wuppertal, Germany.
Lisa EggebrechtPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Vincent Ten CatePreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Marina Panova-NoevaPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Jürgen H ProchaskaPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Karl J LacknerInstitute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Thomas MünzelGerman Center for Cardiovascular Research (DZHK), Partner Site Rhine Main, Mainz, Germany.
Kirsten LeineweberDisease Genomics, Bayer AG, Wuppertal, Germany.
Philipp S WildPreventive Cardiology and Preventive Medicine-Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Miguel A Andrade-NavarroInstitute of Organismic and Molecular Evolution, Johannes Gutenberg University Mainz, Mainz, Germany.
Johannes Gutenberg University Mainz · DEBayer (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted proteomics utilizing antibody-based proximity extension assays provides sensitive and highly specific quantifications of plasma protein levels. Multivariate analysis of this data is hampered by frequent missing values (random or left censored), calling for imputation approaches. While appropriate missing-value imputation methods exist, benchmarks of their performance in targeted proteomics data are lacking. Here, we assessed the performance of two methods for imputation of values missing completely at random, the previously top-benchmarked 'missForest' and the recently published 'GSimp' method. Evaluation was accomplished by comparing imputed with remeasured relative concentrations of 91 inflammation related circulating proteins in 86 samples from a cohort of 645 patients with venous thromboembolism. The median Pearson correlation between imputed and remeasured protein expression values was 69.0% for missForest and 71.6% for GSimp (p = 5.8e-4). Imputation with missForest resulted in stronger reduction of variance compared to GSimp (median relative variance of 25.3% vs. 68.6%, p = 2.4e-16) and undesired larger bias in downstream analyses. Irrespective of the imputation method used, the 91 imputed proteins revealed large variations in imputation accuracy, driven by differences in signal to noise ratio and information overlap between proteins. In summary, GSimp outperformed missForest, while both methods show good overall imputation accuracy with large variations between proteins.

Indexed as

AdultAgedAlgorithmsBiasBlood ProteinsFemaleHumansInterleukin-6Limit of DetectionMaleMiddle AgedMultivariate AnalysisProteomicsQuality ControlVenous ThromboembolismBlood ProteinsInterleukin-6

Identifiers

PMID33315883
PMCPMC7735586
OpenAlexW3111987521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.